+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07220187

Evaluating Pirtobrutinib Plus R-CHOP Compared to R-CHOP Alone for Untreated Richter Transformation A Randomized Phase III Trial

Led by SWOG Cancer Research Network · Updated on 2026-10-13

102

Participants Needed

62

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether adding the drug pirtobrutinib to the usual R-CHOP chemotherapy regimen improves treatment outcomes for people with Richter transformation, a condition where chronic lymphocytic leukemia or small lymphocytic lymphoma changes into a faster-growing large B-cell lymphoma. This phase III trial aims to assess safety and effectiveness of this combination compared to R-CHOP alone, with additional goals to investigate genetic mutations associated with the disease and patient-reported symptoms. Participants are randomly assigned to one of two groups. One group receives pirtobrutinib orally daily on days 1 to 21 of each 21-day cycle along with the R-CHOP drugs given intravenously or subcutaneously during 6 cycles, followed by continued pirtobrutinib for up to 5 years if the disease does not progress. The other group receives only the standard R-CHOP treatment for 6 cycles. Pirtobrutinib and R-CHOP drugs include rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. Some patients may receive an additional treatment cycle if needed. Participants undergo various assessments including heart function tests echocardiography or MUGA scan and imaging scans CT or PETCT throughout the study. Blood and tissue samples are collected for genetic and disease monitoring. Researchers measure progression-free survival, overall survival, response rates, adverse events, and patient-reported symptoms. Follow-up continues for up to 7 years after treatment to monitor long-term outcomes and safety.

CONDITIONS

Brief Title

Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here